Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the Ribonucleic Acid (RNA) Editing Market Heading Into 2029?
The ribonucleic acid (RNA) editing industry has seen significant expansion recently, with projections showing an increase from $16.10 billion in 2024 to $17.55 billion in 2025 – a compound growth rate (CAGR) of 9.0%. This uptrend during the historic period is due to a rise in interest in transient and reversible editing techniques, greater utilization in neurodegenerative disease studies, increasing incidence of rare and orphan illnesses, heightened focus on synthetic biology and bioengineering, along with enhanced academic and translational research efforts.
Forecasting robust expansion in the coming years, the ribonucleic acid (RNA) editing market is set to reach $24.42 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. The market’s expansion during this period is likely to be driven by factors such as a growing prevalence of genetic disorders, an increased emphasis on personalized medicine, a surge in cancer treatment applications, improvements in delivery system technology, and escalating support from government and regulatory bodies. Some significant trends contributing to this projection include technological enhancements in RNA editing platforms, evolution in in vivo delivery technologies, advancement in sequencing and transcriptomics, progression in transient gene modulation methods, and the emergence of synthetic biology applications.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27407&type=smp
Which Factors Are Pushing The Ribonucleic Acid (RNA) Editing Market Forward?
The growing prevalence of genetic disorders is set to drive the expansion of the ribonucleic acid (RNA) editing market. These disorders, stemming from alterations or mutations in genetic material either passed down from parents or emerging spontaneously, are on the rise, largely due to increased parental age. Older parents are more likely to pass on chromosomal irregularities. The RNA editing process can address these disorders by rectifying mutations at the RNA level. This allows cells to generate operational proteins without modifying the DNA underneath. As an example, in May 2024, the Centers for Disease Control and Prevention (CDC), a public health agency in the United States, revealed that around 100,000 people in the country suffer from sickle cell disease (SCD). As such, the increase in genetic disorders is fuelling the ribonucleic acid (RNA) editing market’s growth.
Which Segment Held The Largest Share In The Ribonucleic Acid (RNA) Editing Market In 2025?
The ribonucleic acid (RNA) editing market covered in this report is segmented
1) By Type: Messenger Ribonucleic Acid (RNA) Modification, Transfer Ribonucleic Acid (RNA) Modification, Ribosomal Ribonucleic Acid (RNA) Modification
2) By Technique: Insertion Or Deletion, Deamination
3) By Application: Cancer, Genetic Disorders, Temporary Maladies
Subsegments:
1) By Messenger Ribonucleic Acid (MRNA) Modification: Base Editing, Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing, Site-Directed Ribonucleic Acid(RNA) Editing
2) By Transfer Ribonucleic Acid (TRNA) Modification: Pseudouridylation, Transfer Ribonucleic Acid Splicing, Inosine Modification
3) By Ribosomal Ribonucleic Acid (Rrna) Modification: Pseudouridylation, Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation, Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing
How Are Key Trends Driving Expansion In The Ribonucleic Acid (RNA) Editing Industry?
The focus is on novel methodologies such as in vivo gene editing by key players in the ribonucleic acid (RNA) editing market, which allows for precise and effective remediation of disease-causing genetic alterations within living beings. In vivo gene editing is a cutting-edge technique that corrects genetic deformities or alters gene activity directly within an organism’s cells for therapeutic purposes. To illustrate, the Rett Syndrome Research Trust, an American non-profit organization, initiated the MECP2 Editing Consortium in April 2024 to expedite gene editing treatments for Rett syndrome. Six premier laboratories collaborate through this initiative to develop DNA and RNA editing therapies aimed at tackling the genetic roots of Rett syndrome, with the aim of hastening their progress towards clinical trials. This joint endeavor encourages swift advancement by harnessing collective expertise to provide accurate and potentially healing answers for this severe neurological disease.
Which Organizations Are Driving Progress In The Ribonucleic Acid (RNA) Editing Industry?
Major companies operating in the ribonucleic acid (RNA) editing market are Moderna Inc., Arcturus Therapeutics Holdings Inc., CureVac AG, Beam Therapeutics Inc., EdiGene Inc., Ethris GmbH, Deep Genomics Incorporated, ProQR Therapeutics NV, ReCode Therapeutics, Capstan Therapeutics Inc., TriLink BioTechnologies, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Rznomics Inc., Airna Biotech S.L., hC Bioscience Inc., Korro Bio Inc., Shape TX, and Turn Biotechnologies.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-editing-global-market-report
Which Region Is Expected To Experience The Highest Growth In The Ribonucleic Acid (RNA) Editing Industry?
North America was the largest region in the ribonucleic acid (RNA) editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27407&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model